X-120366624-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001142447.3(ATP1B4):c.163G>A(p.Glu55Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000915 in 1,093,116 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001142447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1B4 | NM_001142447.3 | c.163G>A | p.Glu55Lys | missense_variant | 2/8 | ENST00000218008.8 | NP_001135919.1 | |
ATP1B4 | NM_012069.5 | c.163G>A | p.Glu55Lys | missense_variant | 2/8 | NP_036201.1 | ||
ATP1B4 | XM_017029381.2 | c.163G>A | p.Glu55Lys | missense_variant | 2/5 | XP_016884870.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1B4 | ENST00000218008.8 | c.163G>A | p.Glu55Lys | missense_variant | 2/8 | 1 | NM_001142447.3 | ENSP00000218008.3 | ||
ATP1B4 | ENST00000361319.3 | c.163G>A | p.Glu55Lys | missense_variant | 2/8 | 1 | ENSP00000355346.3 | |||
ATP1B4 | ENST00000539306.5 | c.163G>A | p.Glu55Lys | missense_variant | 2/7 | 2 | ENSP00000443334.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.15e-7 AC: 1AN: 1093116Hom.: 0 Cov.: 30 AF XY: 0.00000279 AC XY: 1AN XY: 358764
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.163G>A (p.E55K) alteration is located in exon 2 (coding exon 2) of the ATP1B4 gene. This alteration results from a G to A substitution at nucleotide position 163, causing the glutamic acid (E) at amino acid position 55 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at